FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1389-1391 November 5, 1998 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Soignet, S. L. PubMed Citation

One of our gentlemen found time to say `How delicious!'" declares Aunt Abby to a mortified Mortimer after he discovers a corpse in the 1944 movie classic Arsenic and Old Lace. The film's portrayal of rapid death after drinking arsenic-spiked elderberry wine epitomizes the public's fearful perception of this poisonous metallic element. The cognoscenti, of course, knew that rapid death was not due to the arsenic but the strychnine and cyanide that were also added to the wine, and that the manifestations of arsenic poisoning are typically not acute. Arsenic poisoning due to contaminated drinking water and industrial pollutants is . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Saunders, G. (2005). Overview of drug therapy for multiple myeloma. J Oncol Pharm Pract 11: 83-100 [Abstract]  
• Brar, S. S., Grigg, C., Wilson, K. S., Holder, W. D. Jr., Dreau, D., Austin, C., Foster, M., Ghio, A. J., Whorton, A. R., Stowell, G. W., Whittall, L. B., Whittle, R. R., White, D. P., Kennedy, T. P. (2004). Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Molecular Cancer Therapeutics 3: 1049-1060 [Abstract] [Full Text]  
• Choe, K. S., Radparvar, F., Matushansky, I., Rekhtman, N., Han, X., Skoultchi, A. I. (2003). Reversal of Tumorigenicity and the Block to Differentiation in Erythroleukemia Cells by GATA-1. Cancer Res. 63: 6363-6369 [Abstract] [Full Text]  
• Penson, R. T., Castro, C. M., Seiden, M. V., Chabner, B. A., Lynch, T. J. Jr. (2001). Complementary, Alternative, Integrative, or Unconventional Medicine?. The Oncologist 6: 463-473 [Abstract] [Full Text]  
• Antman, K. H. (2001). Introduction: The History of Arsenic Trioxide in Cancer Therapy. The Oncologist 6: 1-2 [Abstract] [Full Text]  
• Waxman, S., Anderson, K. C. (2001). History of the Development of Arsenic Derivatives in Cancer Therapy. The Oncologist 6: 3-10 [Abstract] [Full Text]  
• Uslu, R., Sanli, U. A., Sezgin, C., Karabulut, B., Terzioglu, E., Omay, S. B., Goker, E. (2000). Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines. Clin. Cancer Res. 6: 4957-4964 [Abstract] [Full Text]  
• Melnick, A., Licht, J. D. (1999). Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia. Blood 93: 3167-3215 [Full Text]